Fang Evandro F, Lautrup Sofie, Hou Yujun, Demarest Tyler G, Croteau Deborah L, Mattson Mark P, Bohr Vilhelm A
Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA; Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1478 Lørenskog, Norway; Co-first authors.
Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA; Danish Aging Research Center, Department of Molecular Biology and Genetics, University of Aarhus, 8000 Aarhus C, Denmark; Co-first authors.
Trends Mol Med. 2017 Oct;23(10):899-916. doi: 10.1016/j.molmed.2017.08.001. Epub 2017 Sep 9.
The coenzyme NAD is critical in cellular bioenergetics and adaptive stress responses. Its depletion has emerged as a fundamental feature of aging that may predispose to a wide range of chronic diseases. Maintenance of NAD levels is important for cells with high energy demands and for proficient neuronal function. NAD depletion is detected in major neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, cardiovascular disease and muscle atrophy. Emerging evidence suggests that NAD decrements occur in various tissues during aging, and that physiological and pharmacological interventions bolstering cellular NAD levels might retard aspects of aging and forestall some age-related diseases. Here, we discuss aspects of NAD biosynthesis, together with putative mechanisms of NAD action against aging, including recent preclinical and clinical trials.
辅酶NAD在细胞生物能量学和适应性应激反应中至关重要。其消耗已成为衰老的一个基本特征,可能易引发多种慢性疾病。维持NAD水平对于高能量需求的细胞和高效的神经元功能很重要。在主要的神经退行性疾病如阿尔茨海默病和帕金森病、心血管疾病以及肌肉萎缩中都检测到了NAD消耗。新出现的证据表明,衰老过程中各种组织都会出现NAD减少,而增强细胞NAD水平的生理和药物干预可能会延缓衰老并预防一些与年龄相关的疾病。在此,我们讨论NAD生物合成的各个方面,以及NAD对抗衰老的假定作用机制,包括最近的临床前和临床试验。